Giant cell arteritis in Mediterranean countries: Comment on the article by Salvarani et al
✍ Scribed by Miguel A. González-Gay; Marí D. Alonso; Juan J. Agüero; Mercedes Bal; Benjamïn Fernández-Camblor; Amalia Sánchez-Andrade; Carlo Salvarani; Pierluigi Macchioni; Luigi Boiardi; Lorenzo Lodi; Italo Portioli
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 232 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
al report that filtration leukocytapheresis represents an advance in the management of rheumatoid arthritis (1). I do not believe this procedure is as advantageous as centrifugal online lymphoplasmapheresis for the following reasons: 1. Filtration leukocytapheresis removed only 1.9 ϫ 10 9 lymphocyt
The recent article by Prøven et al (Prøven A, Gabriel S, Orces C, O'Fallon WM, Hunder GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003;49:703-8) emphasizes the toxicities inherent in the use of high-dose steroids for the management of giant cell